Fig 1: Summary of the proposed 5-HT3R-mediated downstream signaling pathway underlying 2-Me-5-HT-induced emesis in the least shrew.5-HT3R stimulation by the selective agonist 2-Me-5-HT causes an influx of extracellular Ca2+ through 5-HT3Rs/L-type Ca2+ ion channels which increases the free cytoplasmic concentration of Ca2+, thereby promoting Ca2+ release via calcium-induced calcium release (CICR) from the endoplasmic reticulum stores through ryanodine receptors (RyRs). This elevation in cellular Ca2+ level initiates attachment of calmodulin (CaM) with the 5-HT3R, and leads to CaMKIIα activation and subsequent ERK1/2 signaling. The 5-HT3R antagonist palonosetron(1), the L-type Ca2+ channel blocker amlodipine(2), the RyR blocker dantrolene(3), the CaMKII inhibitor KN93(4), and the ERK inhibitor PD98059(5), respectively exhibit anti-emetic efficacy against 2-Me-5-HT-induced vomiting. These findings demonstrate that the 2-Me-5-HT-induced emesis is regulated by 5-HT3R-mediated Ca2+/CaMKII-dependent ERK signaling pathway.
Fig 2: Activated ACC astrocytes aggravate anxiety‐like behavior and regulate excitatory neurons. (A) Timeline of the experimental procedures; (B and C) The representative tracking plot, time in center zone (left) and total travel distance (right) for OFT (B, n = 11 mice per group) and time in open arm (left) and total distance (right) for EPM test (C, n = 11 mice per group); unpaired t test; (D and F) Immunohistochemical verification of GfaABC1D‐hM3D activation of astrocytes (n = 15 brain slices from 5 mice); unpaired t test; Scale bar:100 μm; (E and G) Immunohistochemical staining and statistical data of c‐fos positive cells in the ACC (n = 15 brain slices from 5 mice); unpaired t test; Scale bar:100 μm; (H, I) Immunohistochemical staining and statistical data of c‐fos positive cells in individual layers in ACC (n = 15 brain slices from 5 mice); Two‐way repeated‐measures ANOVA follow by unpaired t test; Scale bar:100 μm (J) Histogram presenting the percentage of CamKII‐positive cells among c‐fos‐positive cells (n = 6 brain slice from 3 mice); (K) c‐fos colocalized with CamKII after GfaABC1D‐hM3D activation of astrocytes. Scale bar:100 μm. Ns p > 0.05, *p < 0.05, **p < 0.01, **p < 0.01, ****p < 0.0001 SNI 1 week + GfaABC1D‐mCherry versus SNI 1 week + GfaABC1D‐hM3D‐mCherry group.
Fig 3: Effects of CaMKII inhibition on 5-HT3R-mediated emesis.A) The CaMKII inhibitor KN93 (i.p.) or its vehicle was administered to different groups of shrews 30 min prior to 2-Me-5-HT (5 mg/kg, i.p.) injection. The emetic responses were recorded for 30 min following 2-Me-5-HT injection. *P<0.05, **P<0.01 and ***P<0.001 vs. vehicle-pretreated control group. B) Immunoblot analyses of CaMKIIα phosphorylation were performed on brainstems collected from the experimental shrews 20 min after 2-Me-5-HT injection in the absence or presence of KN93 (10 mg/kg, i.p.). n = 3 per group. Graph B shows the fold change from individual experimental results and the insets demonstrate the representative Western blot. *P<0.05 vs. vehicle/vehicle control. #P<0.05 vs. vehicle + 2-Me-5-HT.
Fig 4: Chemogenetic manipulation ACC excitatory neurons can regulate anxiety‐like behavior in SNI mice. (A and B) Timeline of the experimental procedure; (C and E) The representative tracking plot, time in center zone (left) and total travel distance (right) for OFT after CamKII‐hM4D activation of astrocytes (C, n = 11 mice per group) or after CamKII‐hM3D activation of astrocytes (E, n = 10 mice per group); unpaired t test; (D and F) The representative tracking plot, time in center zone (left) and total travel distance (right) for EPM test after CamKII‐hM4D activation of astrocytes (D, n = 11 mice per group) or after CamKII‐hM3D activation of astrocytes (F, n = 10 mice per group); unpaired t test; (G–J) Immunohistochemical staining and statistical analysis of c‐fos positive cells in the ACC (n = 15 brain slices from 5 mice); unpaired t test; Scale bar:100 μm. Ns p > 0.05, *p < 0.05, **p < 0.01, **p < 0.01, ****p < 0.0001 SNI 6 weeks + CamKII‐mCherry versus SNI 6 weeks + CamKII‐hM4D‐mCherry group; SNI 1 week + CamKII‐mCherry versus SNI 1 week + CamKII‐hM3D‐mCherry group.
Fig 5: Organization of the centrifugal input from the PC to the OB. (A,B) Input neurons in the ipsilateral PC following retrograde tracing from the M/TCs (A) and GCs (B). (C) Cumulative distribution of the input neurons in the PC along the AP axis. (D) Subarea distribution of the input neurons in the PC. (E) Laminar distribution of the input neurons in the PC. (F,G) Identification of CaMKII-expressing input neurons in the PC (indicated by arrowheads) following retrograde tracing from the M/TCs (F) and GCs (G). (H) Proportion of CaMKII-expressing input neurons in the PC. Data are shown as the mean ± s.e.m.; gray rhombuses denote individual animals in (D,E,H). Scale bars, 200 µm in (A,B); 50 µm in (F,G). Two-tailed t-tests were used for (D); one-way ANOVA with post-hoc Tukey’s test was used for (E); ** p < 0.01, *** p < 0.001.
Supplier Page from Abcam for Anti-CaMKII alpha antibody